The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome

Details for Australian Patent Application No. 2004229462 (hide)

Owner Progenics Pharmaceuticals, Inc.

Inventors Sanghvi, Suketu P.; Boyd, Thomas A.; Israel, Robert J.

Agent Davies Collison Cave

Pub. Number AU-A-2004229462

PCT Pub. Number WO2004/091622

Priority 60/461,608 08.04.03 US

Filing date 8 April 2004

Wipo publication date 28 October 2004

International Classifications

A61K 031/485 - Morphinan derivatives, e.g. morphine, codeine

A61P 001/00 Drugs for disorders of the alimentary tract or the digestive system

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2004/091622 Priority application(s): WO2004/091622

2 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229463-Pharmaceutical formulations containing methylnaltrexone

2004229461-Method for preparation of site-specific protein conjugates